160 related articles for article (PubMed ID: 16083440)
1. [Ala12]MCD peptide: a lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors.
Buku A; Condie BA; Price JA; Mezei M
J Pept Res; 2005 Sep; 66(3):132-7. PubMed ID: 16083440
[TBL] [Abstract][Full Text] [Related]
2. Effective mast cell degranulating peptide inhibitors of the IgE/Fc epsilonRI receptor interaction.
Buku A; Keselman I; Lupyan D; Mezei M; Price JA
Chem Biol Drug Des; 2008 Aug; 72(2):133-9. PubMed ID: 18624811
[TBL] [Abstract][Full Text] [Related]
3. Histamine-releasing activity and binding to the FcepsilonRI alpha human mast cell receptor subunit of mast cell degranulating peptide analogues with alanine substitutions.
Buku A; Mendlowitz M; Condie BA; Price JA
J Med Chem; 2003 Jul; 46(14):3008-12. PubMed ID: 12825939
[TBL] [Abstract][Full Text] [Related]
4. Partial alanine scan of mast cell degranulating peptide (MCD): importance of the histidine- and arginine residues.
Buku A; Mendlowitz M; Condie BA; Price JA
J Pept Sci; 2004 Jun; 10(6):313-7. PubMed ID: 15214434
[TBL] [Abstract][Full Text] [Related]
5. Mast cell degranulating peptide binds to RBL-2H3 mast cell receptors and inhibits IgE binding.
Buku A; Price JA; Mendlowitz M; Masur S
Peptides; 2001 Dec; 22(12):1993-8. PubMed ID: 11786182
[TBL] [Abstract][Full Text] [Related]
6. Immobilization of Fc epsilon receptors by wheat germ agglutinin. Receptor dynamics in IgE-mediated signal transduction.
McCloskey MA
J Immunol; 1993 Sep; 151(6):3237-51. PubMed ID: 8397254
[TBL] [Abstract][Full Text] [Related]
7. Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cells.
Luiten RM; Warnaar SO; Schuurman J; Pasmans SG; Latour S; Daëron M; Fleuren GJ; Litvinov SV
Hum Antibodies; 1997; 8(4):169-80. PubMed ID: 9395919
[TBL] [Abstract][Full Text] [Related]
8. Relations between Fc epsilon RI crosslinking-induced mast cell activation and adhesion to fibronectin.
Wyczółkowska J; Dastych J; Slusarczyk A; Kolago B
J Physiol Pharmacol; 1994 Dec; 45(4):501-16. PubMed ID: 7537125
[TBL] [Abstract][Full Text] [Related]
9. Amino acid residues that influence Fc epsilon RI-mediated effector functions of human immunoglobulin E.
Sayers I; Cain SA; Swan JR; Pickett MA; Watt PJ; Holgate ST; Padlan EA; Schuck P; Helm BA
Biochemistry; 1998 Nov; 37(46):16152-64. PubMed ID: 9819207
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of binding of rat IgE to rat mast cells by synthetic IgE peptides.
Burt DS; Stanworth DR
Eur J Immunol; 1987 Mar; 17(3):437-40. PubMed ID: 2952512
[TBL] [Abstract][Full Text] [Related]
11. The mast cell binding site on human immunoglobulin E.
Helm B; Marsh P; Vercelli D; Padlan E; Gould H; Geha R
Nature; 1988 Jan; 331(6152):180-3. PubMed ID: 3123993
[TBL] [Abstract][Full Text] [Related]
12. Peptide analogs that inhibit IgE-Fc epsilon RI alpha interactions ameliorate the development of lethal graft-versus-host disease.
Korngold R; Jameson BA; McDonnell JM; Leighton C; Sutton BJ; Gould HJ; Murphy GF
Biol Blood Marrow Transplant; 1997 Oct; 3(4):187-93. PubMed ID: 9360780
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the IgE receptor by tryptic mapping.
Pecoud AR; Conrad DH
J Immunol; 1981 Dec; 127(6):2208-14. PubMed ID: 7299127
[TBL] [Abstract][Full Text] [Related]
14. C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells.
Péterfy H; Tóth G; Pecht I; Erdei A
Int Immunol; 2008 Oct; 20(10):1239-45. PubMed ID: 18653698
[TBL] [Abstract][Full Text] [Related]
15. Generation of canine-human Fc IgE chimeric antibodies for the determination of the canine IgE domain of interaction with Fc epsilon RI alpha.
Hunter MJ; Vratimos AP; Housden JE; Helm BA
Mol Immunol; 2008 Apr; 45(8):2262-8. PubMed ID: 18187193
[TBL] [Abstract][Full Text] [Related]
16. Procyanidin C1 from apple extracts inhibits Fc epsilon RI-mediated mast cell activation.
Nakano N; Nishiyama C; Tokura T; Nagasako-Akazome Y; Ohtake Y; Okumura K; Ogawa H
Int Arch Allergy Immunol; 2008; 147(3):213-21. PubMed ID: 18594151
[TBL] [Abstract][Full Text] [Related]
17. Interaction of a monoclonal IgE-specific antibody with cell-surface IgE-Fc epsilon RI: characterization of equilibrium binding and secretory response.
Posner RG; Paar JM; Licht A; Pecht I; Conrad DH; Hlavacek WS
Biochemistry; 2004 Sep; 43(35):11352-60. PubMed ID: 15366945
[TBL] [Abstract][Full Text] [Related]
18. Gab2 antisense oligonucleotide blocks rat basophilic leukemic cell functions.
Chan JH; Liao W; Lau HY; Wong WS
Int Immunopharmacol; 2007 Jul; 7(7):937-44. PubMed ID: 17499196
[TBL] [Abstract][Full Text] [Related]
19. Super-oxidized solution inhibits IgE-antigen-induced degranulation and cytokine release in mast cells.
Medina-Tamayo J; Sánchez-Miranda E; Balleza-Tapia H; Ambriz X; Cid ME; González-Espinosa D; Gutiérrez AA; González-Espinosa C
Int Immunopharmacol; 2007 Aug; 7(8):1013-24. PubMed ID: 17570318
[TBL] [Abstract][Full Text] [Related]
20. Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis.
Tanaka A; Tanaka T; Suzuki H; Ishii K; Kameyoshi Y; Hide M
Exp Dermatol; 2006 Apr; 15(4):283-90. PubMed ID: 16512875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]